Medication & Safety
Return and Refund Policy: What to Check Before You Buy
A clear return and refund policy tells you a lot about a seller before anything goes wrong. Here is what to check before...
Most people starting Wegovy will experience some side effects, and the majority of those effects are digestive, dose-related and temporary. Knowing which is which saves a lot of unnecessary worry, and it also helps you recognise the small number of symptoms that genuinely need a doctor the same day.
Wegovy is semaglutide at weight management doses, given as a weekly injection. This guide covers what the trials recorded, what to expect week by week, and where the real red lines are.
Why side effects happen at all
Wegovy works by mimicking GLP-1 (glucagon-like peptide-1, a hormone your gut releases after eating). One of the things this hormone does naturally is slow down how fast your stomach empties.
That slowing is not a malfunction. It is the mechanism. Food staying in your stomach longer is precisely why you feel full sooner and for longer.
The side effects follow directly from that. When your stomach empties more slowly than it used to, nausea, fullness, reflux and altered bowel habits are the predictable consequence. This is why almost every common Wegovy side effect is digestive.
It also explains why the effects are worst right after a dose increase and settle as your body adapts.
The common side effects
These were the most frequently reported effects in the STEP trial programme, published in the New England Journal of Medicine.
Nausea. The most common by a clear margin, affecting roughly 40 percent of users. Usually mild to moderate, worst in the first days after a dose step-up, and generally improving within a few weeks at a stable dose.
Diarrhoea. Around 30 percent. Often intermittent rather than constant.
Vomiting. Roughly 24 percent. More common at higher doses and in people who eat large or fatty meals.
Constipation. Around 24 percent. Slowed gut transit plus reduced food and fluid intake combine to cause this.
Abdominal pain. Around 20 percent. Usually cramping or bloating rather than severe pain.
Headache, fatigue, dizziness. Common and usually related to eating and drinking less rather than to the drug directly.
Burping and reflux. Frequently reported, sometimes with a sulfur smell that people find distressing. Unpleasant, not dangerous.
Injection site reactions. Redness or itching at the site. Usually minor and short-lived.
Most people get some of these. Very few get all of them.
What the timeline usually looks like
Weeks 1 to 4 (0.25 mg). This starting dose is deliberately below the effective range. Its only purpose is to let your gut adapt. Side effects are usually mild here. Some people feel almost nothing.
Each dose increase. Expect two to five days of heightened nausea after each step up. This is the pattern most people report. It settles.
Months 2 to 4. As doses climb toward 2.4 mg, this is when side effects peak for most users. It is also when most discontinuation happens.
Beyond month 4. At a stable maintenance dose, most people report their side effects have substantially reduced or resolved.
If your side effects are getting worse rather than better at a stable dose, that is worth raising with your doctor. That is not the expected pattern.
Managing the common effects
Much of what makes nausea unbearable is behavioural rather than pharmacological.
- Eat smaller portions. Your stomach genuinely holds less now. Serving your old portion size and pushing through it is the single most common cause of vomiting.
- Stop eating when you feel full rather than when the plate is empty.
- Reduce fatty and fried foods. Fat slows stomach emptying further, compounding the drug effect.
- Drink water steadily through the day. Dehydration worsens nausea, headache and constipation together.
- Increase fibre gradually for constipation, and keep moving.
- Avoid lying down straight after eating if reflux is a problem.
- Do not rush the dose escalation. If a dose is hard, staying at it longer before stepping up is usually better than pushing on.
The serious risks
These are uncommon, but they are the reason GLP-1 medication should be physician-supervised rather than self-managed.
Pancreatitis. Inflammation of the pancreas. The warning sign is severe, persistent abdominal pain, often radiating through to your back, frequently with vomiting. This is not ordinary nausea. It does not settle. Seek urgent medical care.
Gallbladder disease. Gallstones and gallbladder inflammation occur more often on GLP-1 medication, partly because rapid weight loss itself raises gallstone risk. Watch for pain in the upper right abdomen, particularly after fatty meals, sometimes with fever or yellowing of the skin or eyes.
Kidney problems. Usually a downstream consequence of dehydration from prolonged vomiting or diarrhoea rather than a direct drug effect. Reduced urine output and marked dizziness on standing are the signals.
Severe hypoglycaemia. Low blood sugar. Rare on Wegovy alone, but a genuine risk if you also take insulin or sulfonylureas. Doses of those often need adjusting.
Thyroid C-cell tumours. Seen in rodent studies. Whether this translates to humans is not established. Wegovy is not used in anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.
Gastroparesis. Severely delayed stomach emptying that persists. Rare, but reported, and sometimes lasting after stopping.
Vision changes in diabetic retinopathy. Rapid blood sugar improvement can temporarily worsen existing retinopathy. Anyone with diabetic eye disease needs monitoring.
If you develop severe abdominal pain, persistent vomiting that stops you keeping fluids down, signs of an allergic reaction, or sudden vision changes, speak with a specialist or attend an emergency department. These are not symptoms to manage at home.
What the cardiovascular data showed
It is worth putting the risk picture in balance, because side-effect lists read alarmingly on their own.
The SELECT cardiovascular outcomes trial, published in 2023, followed adults with obesity and existing cardiovascular disease but without diabetes. Semaglutide reduced major adverse cardiovascular events compared with placebo.
So the same drug that causes a lot of nausea also reduced heart attacks and strokes in that population. Both facts are true. A sensible decision weighs them together rather than reading either in isolation.
Side effects that are not the drug
Some things people blame on Wegovy are consequences of losing weight quickly rather than the medication itself.
Hair shedding is the most common example. Rapid weight loss of any cause can trigger telogen effluvium, a temporary shedding phase where more hairs than usual enter the resting stage. It typically shows up two to three months after rapid loss begins and recovers on its own.
Facial volume loss follows the same logic. Fat is lost from the face along with everywhere else. That is weight loss, not a drug effect.
Muscle loss is real and worth taking seriously. Any substantial calorie deficit costs some lean tissue. Adequate protein and resistance exercise reduce it considerably.
Where physician oversight matters most
The pattern across all of this is that the manageable effects need adjustment and the serious ones need recognition. Both require someone medically qualified paying attention.
This is the practical argument for physician-guided programs over self-sourced medication. In Pakistan, where GLP-1 injections mostly arrive through informal import channels without any clinical supervision attached, that gap is the real safety concern.
METASLIM™ takes a different route. It is a physician-reviewed GLP-1 sublingual supplement rather than a pharmaceutical GLP-1 receptor agonist, and because it is sublingual and dosed differently, it has a different side effect profile with generally milder gastrointestinal effects. What matters more here is that every order goes through physician-reviewed sublingual drops rather than an unsupervised purchase. A doctor screens your history before anything ships, which is the step most informal GLP-1 supply in this market skips entirely.
For the full picture on the diabetes-dose product, our guide to Ozempic side effects covers the same molecule at different doses, and Ozempic alternatives compares tolerability across the whole class.
The realistic summary
Most Wegovy side effects are digestive, predictable, dose-related and temporary. They are worst during escalation and settle at a stable dose. Behaviour changes around portion size, fat intake and hydration make a substantial difference to how bad they get.
A small number of effects are serious and need immediate attention rather than patience. Knowing that list is what makes the difference.
If you are weighing this decision, get started with a physician review rather than sourcing medication without clinical oversight.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.